Halil Şenol

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Molecular Docking

Density Functional Theory

Methicillin Resistant Staphylococcus Aureus

Small Cell Lung Cancer

Top Venues

Turkish journal of chemistry

Chemical biology & drug design

Journal of biomolecular structure & dynamics

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Feyzi Sinan Tokalı, Halil Şenol, Şeyma Ateşoğlu, Fahri Akbas
A series of quinazolin-4(3H)-one-morpholine hybrids as anti-lung-cancer agents: Synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies. Chemical biology & drug design 104 (1) (2024)
Shahla Tahirli, Fargana Aliyeva, Halil Şenol, Svetlana Demukhamedova, Gulnara Akverdieva, Irada Aliyeva, Sitara Veysova, Nastaran Sadeghian, Sevilay Günay, Yavuz Erden, Parham Taslimi, Afsun Sujayev, Famil Chiragov
Novel complex compounds of nickel with 3-(1-phenyl-2,3-dimethyl-pyrazolone-5)azopentadione-2,4: synthesis, NBO analysis, reactivity descriptors and in silico and in vitro anti-cancer and bioactivity studies. Journal of biomolecular structure & dynamics (2024)
Gülbahar Özge Alim Toraman, Halil Şenol, Seçil Yazıcı Tütüniş, Nur Tan, Gulacti Topcu
Phytochemical analysis and molecular docking studies of two endemic varieties of Salvia sericeotomentosa . Turkish journal of chemistry 47 (5) (2023)
Gülbahar Özge Alim Toraman, Halil Şenol, Seçil Yazıcı Tütüniş, Nur Tan, Gulacti Topcu
Phytochemical analysis and molecular docking studies of two endemic varieties of Salvia sericeotomentosa . Turkish journal of chemistry 47 (5) (2023)
Feyzi Sinan Tokalı, Halil Şenol, Hande İpek Yetke, Ebru Hacıosmanoğlu-Aldoğan
Novel quinazoline-chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies. Archiv der Pharmazie (2023)
Halil Şenol, Rabia Büşra Şahin, Berre Mercümek, Halil Burak Kapucu, Ebru Hacıosmanoğlu, Harika Öykü Dinç, Pelin Yüksel Mayda
Synthesis of ursolic acid arylidene-hydrazide hybrid compounds and investigation of their cytotoxic and antimicrobial effects. Natural product research (2022)